Skip to main content

Swiss National Bank

Bank

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1582202 ZURICH, V8

Position in NTLA

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$2,792,196
+$985,206 QoQ
Shares Held
217,800
+8.4% QoQ
Ownership
0.156%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. NTLA ranks #82 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NTLA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,792,196 217,800
2025-12-31 $1,806,990 201,000
2025-09-30 $3,293,389 190,700
2025-06-30 $1,757,812 187,400
2025-03-31 $1,332,414 187,400
2024-12-31 $2,211,902 189,700
2024-09-30 $3,678,450 179,000
2024-06-30 $4,035,114 180,300
2024-03-31 $4,618,929 167,900
2023-12-31 $5,052,193 165,700
2023-09-30 $5,514,528 174,400
2023-06-30 $7,034,550 172,500
2023-03-31 $5,694,856 152,800
2022-12-31 $5,763,828 165,200
2022-09-30 $9,059,924 161,900
2022-06-30 $8,167,728 157,800
2022-03-31 $11,510,928 158,400
2021-12-31 $17,203,920 145,500
2021-09-30 $18,190,740 135,600
2021-06-30 $21,760,704 134,400
2021-03-31 $8,667,540 108,000
2020-12-31 $5,777,280 106,200
2020-09-30 $2,049,628 103,100
2020-06-30 $2,135,632 101,600
2020-03-31 $801,065 65,500